Home/Filings/4/0001886794-26-000002
4//SEC Filing

Dhaliwal Harpreet S. 4

Accession 0001886794-26-000002

CIK 0001649094other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 4:21 PM ET

Size

5.2 KB

Accession

0001886794-26-000002

Insider Transaction Report

Form 4
Period: 2025-12-31
Dhaliwal Harpreet S.
Chief Technical Ops Officer
Transactions
  • Sale

    Common Stock

    2025-12-31$46.69/sh9,743$454,89123,928 total
Footnotes (2)
  • [F1]The price reported is a weighted-average price. The shares were sold at prices ranging from $46.42 to $47.155. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F2]Includes one (1) share acquired on November 17, 2025 under the Issuer's Employee Stock Purchase Plan.

Issuer

Vaxcyte, Inc.

CIK 0001649094

Entity typeother

Related Parties

1
  • filerCIK 0001886794

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:21 PM ET
Size
5.2 KB